Cetera Advisor Networks LLC Invitae Corp Transaction History

Cetera Advisor Networks LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.6 - $1.53 $581 - $1,482	-969 Reduced 3.62%	25,823 $15,000
Q2 2023 Aug 09, 2023	BUY	$1.05 - $1.63 $5,058 - $7,853	4,818 Added 21.93%	26,792 $30,000
Q1 2023 May 15, 2023	BUY	$1.2 - $2.73 $12,184 - $27,720	10,154 Added 85.91%	21,974 $29,000
Q4 2022 Feb 14, 2023	BUY	$1.71 - $3.61 $20,212 - $42,670	11,820 New	11,820 $21,000
Q3 2020 Nov 13, 2020	SELL	$28.43 - $44.67 $33,831 - $53,157	-1,190 Closed	0 $0

Q2 2020 Aug 13, 2020	BUY	$11.71 - $30.29 $13,934 - $36,045	1,190 New	1,190 $36,000
Q1 2020 May 08, 2020	SELL	$7.64 - $27.5 $276,759 - $996,187	-36,225 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$15.02 - $20.57 $49,566 - $67,881	-3,300 Reduced 8.35%	36,225 $582,000
Q3 2019 Nov 06, 2019	BUY	$18.85 - $27.5 $303,485 - $442,750	16,100 Added 68.73%	39,525 $781,000
Q2 2019 Aug 12, 2019	SELL	$17.37 - $26.27 $193,241 - $292,253	-11,125 Reduced 32.2%	23,425 $559,000
Q1 2019 May 06, 2019	BUY	$10.65 - $25.75 $167,205 - $404,275	15,700 Added 83.29%	34,550 $818,000
Q3 2018 Nov 14, 2018	BUY	$7.54 - $18.31 $11,310 - $27,464	1,500 Added 8.65%	18,850 $317,000
Q2 2018 Aug 14, 2018	BUY	$4.87 - $8.42 $84,494 - $146,087	17,350 New	17,350 $129,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisor Networks LLC with notifications on news.